Best therapies for relapsed diffuse large b-cell lymphoma

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/best-therapies-for-relapsed/id431848... . When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma...

Proton therapy treatment for glioblastoma

submitted by: mdanderson

Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive. Paul Brown, M.D., professor in Radiation Oncology at MD Anderson Cancer Center, discusses a ground-breaking clinical trial that treats glioblastoma with intensity modulated proton therapy (IMPT). Also in this podcast, Brown explains other new discoveries in adult and childhood brain cancer research and the importance of a skilled proton therapy center.

Crevicular fluid biomarkers and periodontal disease progression

submitted by: Janet Kinney
AIM: Assess the ability of a panel of gingival crevicular fluid (GCF) biomarkers as predictors of periodontal disease progression (PDP). MATERIALS AND METHODS: 100 individuals participated in a 12-month longitudinal investigation and categorized into 4 groups according to their periodontal status. GCF, clinical parameters, and saliva were collected bi-monthly. Sub-gingival plaque and serum were collected bi-annually. For 6 months, no periodontal treatment was provided. At 6-months,...
Authors: Thomas Braun, William Giannobile, Janet Kinney, Thiago Morelli, Min Oh, Christoph Ramseier, James Sugai

Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial.

submitted by: rumoreno
AIM: To compare the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) in an absorbable collagen sponge carrier (ACS) with autogenous bone graft for augmentation of the edentulous atrophic anterior maxilla. METHODS: Twenty-four subjects were enrolled in a randomized, controlled, parallel-group, open-label clinical trial. Subjects either received rhBMP-2/ACS (1.5 mg/ml) or particulated autogenous bone harvested from the mandibular retromolar region. A titanium-mesh was used...
Authors: Rubens Freitas

Effects of vitamin C and D administration on mood and distress in acutely hospitalized patients

submitted by: LJHOFFER
Background: Hypovitaminosis C and D are highly prevalent in acute-care hospitals. Malnutrition with regard to these vitamins has been linked to mood disturbance and cognitive dysfunction. Objective: To determine whether vitamin C or D supplementation improves mood state or reduces psychological distress in acutely hospitalized patients with a high prevalence of hypovitaminosis C and D. Methods: Randomized, double-blind, active-control clinical trial comparing the effect of vitamin C (500...
Authors: Yifan Yang, Xing Jian Liu, Line Robitaille, Shaun Eintracht, Elizabeth MacNamara, L. John Hoffer

Regenerative Medicine Primer

submitted by: WentzMR
Dr. Andre Terzic, from Mayo Clinic in Rochester, MN, and Director of the enterprise-wide Center for Regenerative Medicine reviews his article appearing in the July 2013 issue of Mayo Clinic Proceedings, regarding the upcoming forum dedicated to regenerative medicine and surgery. Across specialties, the emerging tools, principles, and practices of regenerative medicine are at the core of transforming healthcare. Available at: http://tinyurl.com/ltwjdrj

Introduction to the Symposium on Regenerative Medicine

submitted by: WentzMR
Dr. Eric Matteson, Chair of the Division of Rheumatology at Mayo Clinic in Rochester, MN, discusses the Symposium on Regenerative Medicine launched with the July 2013 issue of Mayo Clinic Proceedings. This first-of-its-kind compendium on the developing field of regenerative medicine and surgery, presented by leading experts, highlights new vistas in treatment options for patients. Available at: http://tinyurl.com/ka9jjzy

Non-Hodgkin’s lymphoma basics

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/non-hodgkins-lymphoma-basics/id43184... Non-Hodgkin’s lymphoma is the seventh most common cancer in men and women in the United States and often misdiagnosed by primary care doctors. Symptoms may include headaches, confusion, nausea and fatigue. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses the basics of non-Hodgkin’s lymphoma including symptoms, diagnosis, treatment and...

New Lung Cancer Screening Offered At MD Anderson

submitted by: mdanderson

Results from national clinical trial mobilizes a team of experts to develop Lung Cancer Screening Program. For appointment contact AskMDAnderson 877-MDA-6789 https://www2.mdanderson.org/sapp/contact/selfreferral/index.cfm

New solution for therapeutic cancer vaccine failure

submitted by: mdanderson
http://www.mdanderson.org/newsroom/news-releases/2013/cancer-vaccines-ch... Vaccines designed to turn the immune system against cancer have been logically constructed and tested against many cancers. Almost all have failed or shown minimal effect. They spark creation of killer T cells against the cancer, but generally have little effect on tumors, both in patients and mouse models. Willem Overwijk, Ph.D., and colleagues at MD Anderson discovered that a common vaccine component is...